Collaboration to Focus on Therapeutics for ADPKD

摘要

The University of Sheffield and Mironid Ltd, a leader in cell signalling-directed drug development, are collaborating to identify and develop new molecules for the treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD). The partnership will focus on advancing Mironid's proprietary LoAc~R molecules towards clinical development, with the aim of producing new therapies that can improve the health of patients.